These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2280310)

  • 1. [Suppression of evoked otoacoustic emissions by contralateral noise exposure in humans].
    Abe T; Tsuiki T; Ito S; Endo Y; Suzuki K; O-Uchi T
    Nihon Jibiinkoka Gakkai Kaiho; 1990 Nov; 93(11):1890-7. PubMed ID: 2280310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contralateral auditory stimulation alters acoustic distortion products in humans.
    Moulin A; Collet L; Duclaux R
    Hear Res; 1993 Feb; 65(1-2):193-210. PubMed ID: 8458751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olivocochlear activity and temporary threshold shift-susceptibility in humans.
    Wagner W; Heppelmann G; Kuehn M; Tisch M; Vonthein R; Zenner HP
    Laryngoscope; 2005 Nov; 115(11):2021-8. PubMed ID: 16319617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of contralateral acoustic stimulation on active cochlear micromechanical properties in human subjects: dependence on stimulus variables.
    Veuillet E; Collet L; Duclaux R
    J Neurophysiol; 1991 Mar; 65(3):724-35. PubMed ID: 2051201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of olivocochlear bundle section on otoacoustic emissions in humans: efferent effects in comparison with control subjects.
    Williams EA; Brookes GB; Prasher DK
    Acta Otolaryngol; 1994 Mar; 114(2):121-9. PubMed ID: 8203191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The application of otoacoustic emissions measurement in the assessment of the function of cochlear efferent fibers: the study of normal hearing subjects].
    Kotyło P; Sliwińska-Kowalska M
    Otolaryngol Pol; 1999; 53(1):87-93. PubMed ID: 10337165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medial olivocochlear efferent system in humans studied with amplitude-modulated tones.
    Maison S; Micheyl C; Collet L
    J Neurophysiol; 1997 Apr; 77(4):1759-68. PubMed ID: 9114234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cochlear Nerve Aplasia with Detectable Olivocochlear Efferent Function: A Distinct Presentation of Auditory Neuropathy Spectrum Disorder.
    James AL; Dixon PR; Harrison RV
    Audiol Neurootol; 2018; 23(1):39-47. PubMed ID: 29936500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study on the contralateral suppressive effects of distortion product otoacoustic emissions].
    Wang H; Zhong N
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1997 Nov; 11(11):489-92. PubMed ID: 10323015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization of the TEOAE Contralateral Suppression Test in Terms of Stimulus Intensity and Contralateral Noise Duration in Individuals with Normal Hearing.
    Celikgun B; Derinsu U
    J Am Acad Audiol; 2022 Jan; 33(1):29-35. PubMed ID: 35512841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contralateral auditory stimulation and otoacoustic emissions: a review of basic data in humans.
    Collet L; Veuillet E; Moulin A; Morlet T; Giraud AL; Micheyl C; Chéry-Croze S
    Br J Audiol; 1994; 28(4-5):213-8. PubMed ID: 7735149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ipsilateral suppression of transient evoked otoacoustic emission: role of the medial olivocochlear system.
    Tavartkiladze GA; Frolenkov GI; Artamasov SV
    Acta Otolaryngol; 1996 Mar; 116(2):213-8. PubMed ID: 8725517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of contralateral auditory stimuli on active cochlear micro-mechanical properties in human subjects.
    Collet L; Kemp DT; Veuillet E; Duclaux R; Moulin A; Morgon A
    Hear Res; 1990 Jan; 43(2-3):251-61. PubMed ID: 2312416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tone-burst and click-evoked otoacoustic emissions in subjects with hearing loss above 0.25, 0.5, and 1 kHz.
    Jedrzejczak WW; Kochanek K; Trzaskowski B; Pilka E; Skarzynski PH; Skarzynski H
    Ear Hear; 2012; 33(6):757-67. PubMed ID: 22710662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Auditory neuropathy].
    Liang F; Liu C; Liu B
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Dec; 34(6):350-2. PubMed ID: 12764843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of medial olivocochlear efferent system in humans: influence of stimulus bandwidth.
    Maison S; Micheyl C; Andéol G; Gallégo S; Collet L
    Hear Res; 2000 Feb; 140(1-2):111-25. PubMed ID: 10675639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of transient-evoked and distortion product otoacoustic emissions in normal-hearing and hearing-impaired subjects.
    Gorga MP; Neely ST; Bergman BM; Beauchaine KL; Kaminski JR; Peters J; Schulte L; Jesteadt W
    J Acoust Soc Am; 1993 Nov; 94(5):2639-48. PubMed ID: 8270740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical dysfunction of cochlea and cochlear efferents in migraine: an otoacoustic emission study.
    Bolay H; Bayazit YA; Gündüz B; Ugur AK; Akçali D; Altunyay S; Ilica S; Babacan A
    Cephalalgia; 2008 Apr; 28(4):309-17. PubMed ID: 18279433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contralateral suppression of transient-evoked otoacoustic emissions in humans: intensity effects.
    Hood LJ; Berlin CI; Hurley A; Cecola RP; Bell B
    Hear Res; 1996 Nov; 101(1-2):113-8. PubMed ID: 8951438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evoked otoacoustic emissions in noise-induced hearing loss].
    Bicciolo G; Ruscito P; Rizzo S; Frenguelli A
    Acta Otorhinolaryngol Ital; 1993; 13(6):505-15. PubMed ID: 8209689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.